Voloridge Investment Management
NKTR icon

Voloridge Investment Management’s Nektar Therapeutics NKTR Stock Holding History

Voloridge Investment Management’s Portfolio NKTR Stock Details NKTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-295,716
Closed -$12.5M – 1189
2025
Q4 		$12.5M Buy
295,716
+123,940
+72% +$6.94M 0.04% 516
2025
Q3 		$9.77M Buy
+171,776
New +$5.69M 0.03% 546
2022
Q3 		– Sell
-12,789
Closed -$729K – 1552
2022
Q2 		$729K Buy
12,789
+11,752
+1,133% +$741K ﹤0.01% 1258
2022
Q1 		$84K Buy
+1,037
New +$153K ﹤0.01% 1316
2021
Q1 		– Sell
-17,042
Closed -$4.35M – 1570
2020
Q4 		$4.35M Buy
17,042
+5,386
+46% +$1.39M 0.04% 493
2020
Q3 		$2.9M Buy
11,656
+9,767
+517% +$3.07M 0.02% 598
2020
Q2 		$656K Buy
+1,889
New +$589K 0.01% 965
2019
Q4 		– Sell
-9,965
Closed -$2.72M – 1269
2019
Q3 		$2.72M Buy
9,965
+3,813
+62% +$1.4M 0.05% 376
2019
Q2 		$3.28M Buy
+6,152
New +$3.08M 0.09% 232
2019
Q1 		– Sell
-21,576
Closed -$10.6M – 1022
2018
Q4 		$10.6M Buy
+21,576
New +$13M 0.48% 53
2018
Q2 		– Sell
-153
Closed -$244K – 541
2018
Q1 		$244K Sell
153
-10,151
-99% -$13.1M 0.01% 460
2017
Q4 		$9.23M Buy
+10,304
New +$6.09M 0.2% 125

Other funds holding NKTR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Voloridge Investment Management's NKTR Position: Q1 2026 in Review

Voloridge Investment Management sold out of Nektar Therapeutics (NKTR) in Q1 2026, closing a stake of 295,716 shares — an estimated $12.5M sold.

Voloridge Investment Management first reported a position in NKTR in Q4 2017 and held it in 12 quarters. The position peaked at $12.5M in Q4 2025. 215 funds tracked by Wall St. Rank hold NKTR as of Q1 2026.

  • Voloridge Investment Management reported no remaining Nektar Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Voloridge Investment Management sold 295,716 Nektar Therapeutics shares in Q1 2026, an estimated $12.5M.
  • Voloridge Investment Management first reported a position in Nektar Therapeutics in Q4 2017 and held it in 12 quarters.
  • Voloridge Investment Management's Nektar Therapeutics position peaked at $12.5M in Q4 2025.
  • 215 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q1 2026.

Based on Voloridge Investment Management's 13F filing for Q1 2026, filed 15 May 2026.